On Tuesday, Corvus Pharmaceuticals Inc (NASDAQ: CRVS) opened lower -5.51% from the last session, before settling in for the closing price of $7.8. Price fluctuations for CRVS have ranged from $2.54 to $9.60 over the past 52 weeks.
Healthcare Sector giant saw their annual sales surged by 8.47% over the last five years. Company’s average yearly earnings per share was noted 58.29% at the time writing. With a float of $57.33 million, this company’s outstanding shares have now reached $74.68 million.
The firm has a total of 31 workers. Let’s measure their productivity.
Corvus Pharmaceuticals Inc (CRVS) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Corvus Pharmaceuticals Inc is 23.24%, while institutional ownership is 37.72%. The most recent insider transaction that took place on Jun 27 ’25, was worth 4,891,894. In this transaction Director of this company sold 1,176,332 shares at a rate of $4.16, taking the stock ownership to the 7,165,006 shares. Before that another transaction happened on Jun 27 ’25, when Company’s Director sold 1,176,332 for $4.16, making the entire transaction worth $4,891,894. This insider now owns 7,165,006 shares in total.
Corvus Pharmaceuticals Inc (CRVS) Earnings and Forecasts
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted -0.14 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -0.12) by -0.02. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.14 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 58.29% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 17.36% during the next five years compared to 8.47% growth over the previous five years of trading.
Corvus Pharmaceuticals Inc (NASDAQ: CRVS) Trading Performance Indicators
Check out the current performance indicators for Corvus Pharmaceuticals Inc (CRVS). In the past quarter, the stock posted a quick ratio of 8.29.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.53, a number that is poised to hit -0.13 in the next quarter and is forecasted to reach -0.55 in one year’s time.
Technical Analysis of Corvus Pharmaceuticals Inc (CRVS)
Analysing the last 5-days average volume posted by the [Corvus Pharmaceuticals Inc, CRVS], we can find that recorded value of 2.36 million was better than the volume posted last year of 0.9 million. As of the previous 9 days, the stock’s Stochastic %D was 10.14%.
During the past 100 days, Corvus Pharmaceuticals Inc’s (CRVS) raw stochastic average was set at 59.81%, which indicates a significant increase from 1.33% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.54 in the past 14 days, which was higher than the 0.46 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $8.07, while its 200-day Moving Average is $5.41. Now, the first resistance to watch is $7.67. This is followed by the second major resistance level at $7.96. The third major resistance level sits at $8.13. If the price goes on to break the first support level at $7.21, it is likely to go to the next support level at $7.04. Should the price break the second support level, the third support level stands at $6.75.
Corvus Pharmaceuticals Inc (NASDAQ: CRVS) Key Stats
There are currently 74,682K shares outstanding in the company with a market cap of 550.41 million. Presently, the company’s annual sales total 0 K according to its annual income of -62,290 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -10,160 K.
